查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1971524

矽膠非正規敷料市場 - 全球產業規模、佔有率、趨勢、機會、預測、區域及競爭格局（2021-2031年）

Non-Silicone Foam Dressings Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 188 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球非矽泡棉敷料市場預計將從 2025 年的 5.5212 億美元成長到 2031 年的 7.2772 億美元，複合年成長率為 4.71%。

這些產品通常由聚氨酯泡棉和丙烯酸黏合劑或非黏合劑介面組成，旨在促進潮濕環境下的創傷治療，同時有效吸收中度至重度滲出液。與矽基替代品相比，其成本優勢是推動該市場發展的主要因素，因此在預算緊張的醫療保健系統中備受青睞。慢性傷口（例如糖尿病潰瘍）在全球發病率的上升進一步刺激了這一需求。例如，英國糖尿病協會2024年5月發布的報告指出，過去五年中，青少年第二型糖尿病的診斷數量增加了約40%，凸顯了易患該疾病的人群日益增多，而有效的傷口管理至關重要。

市場概覽
預測期 2027-2031
市場規模：2025年 5.5212億美元
市場規模：2031年 7.2772億美元
複合年成長率：2026-2031年 4.71%
成長最快的細分市場
最大的市場 北美洲

儘管存在這些成長要素，但市場仍面臨與皮膚健康相關的重大挑戰。這是因為刺激性強的非矽酮黏合劑，與溫和的矽酮產品不同，在移除時可能會造成疼痛和創傷。與醫用黏合劑相關的皮膚損傷風險促使臨床醫生和患者更傾向於使用矽酮敷料，從而限制了非矽酮產品的普及。在敏感脆弱肌膚的應用中，這種趨勢尤其明顯，因為在這些情況下，最大限度地減少創傷至關重要。因此，儘管成本效益吸引了市場關注，但皮膚損傷的可能性仍然是限制該細分市場在高風險護理環境中擴張的主要阻礙因素。

市場促進因素

全球慢性傷口（尤其是糖尿病足潰瘍）盛行率的不斷上升，是推動全球非矽泡棉敷料市場成長要素。糖尿病患者由於神經病變和血液作用不良等併發症，容易出現難癒合的潰瘍，因此迫切需要能夠吸收大量滲出液的敷料。非矽泡棉敷料因其比矽基敷料更經濟實惠且具有更優異的引流性能，在這些情況下已廣泛應用。這使得它們在擁有龐大患者群體的醫療系統中不可或缺。根據國際糖尿病聯盟（IDF）於2025年4月更新的《糖尿病地圖集》，目前全球約有5.89億20至79歲的成年人患有糖尿病，這是一個龐大的患者群體，他們面臨著發生潰瘍的風險以及相關的創傷護理需求。

同時，人口老化顯著推高了市場需求。老年人由於老齡化相關的皮膚脆弱和缺乏運動，特別容易患上靜脈性腿部潰瘍和壓瘡。這種人口結構的變化凸顯了養老院和居家醫療機構對有效且經濟的創傷護理解決方案的需求，使得非矽泡沫敷料成為治療壓瘡的標準工具。根據世界衛生組織（世衛組織）於2025年10月發布的《老化與健康》概況介紹，預計到2050年，60歲及以上人口的比例將從2015年的12%幾乎加倍，達到22%。這種需求的成長與產業績效密切相關。例如，史密斯醫療（Smith & Nephew）於2025年8月發布的《2025年第二季度和上半年財務業績》顯示，創傷護理業務部門的核心收入成長了2.6%，這主要得益於泡沫敷料產品線的銷售成長。

市場挑戰

全球非矽泡棉敷料市場成長的主要障礙是強力黏合劑造成的皮膚損傷風險，即醫用黏合劑相關性皮膚損傷。與矽膠敷料溫和的剝離方式不同，非矽敷料中常用的橡膠或丙烯酸類黏合劑形成的黏合力過強，會對嬌嫩的皮膚組織造成損傷。移除這些敷料會導致皮膚表層剝落，造成劇烈疼痛和繼發性傷口。這種損傷風險使得醫護人員在為老年患者或皮膚脆弱的患者選擇非矽敷料時猶豫不決，從而限制了此類產品在以皮膚保護為首要任務的臨床環境中的應用。

這種猶豫不決極大地限制了非矽酮敷料的潛在市場，因為最需要泡沫敷料的患者群體通常具有不適合強力黏附的皮膚特性。考慮到需要長期傷口管理的患者數量龐大，而他們原本都是這些經濟有效的解決方案的適用人群，這種限制的嚴重性就顯而易見了。根據歐洲傷口管理協會的數據，到2024年，歐洲地區約有400萬人患有慢性傷口。如此龐大的患者群體需要頻繁更換敷料，這表明無法安全保護脆弱的皮膚直接阻礙了非矽酮敷料市場的成長潛力。

市場趨勢

隨著醫療系統將主動感染控制與液體管理並重，先進抗菌劑和生物活性劑的整合正在改變這一領域。這一趨勢推動了含有銀和聚六亞甲基雙胍（PHMB）等活性劑的非矽泡沫敷料的研發，為慢性潰瘍生物膜管理提供了一種比昂貴的矽基產品更具成本效益的替代方案。這些增值解決方案的發展勢頭在行業數據中顯而易見。例如，根據史密斯醫療（Smith & Nephew）於2025年11月發布的2025年第三季財報，其先進傷口生物活性業務的核心收入成長了12.2%，顯著高於其他業務板塊，凸顯了市場對化學活性敷料界面日益成長的需求。

同時，能夠即時監測傷口的智慧感測器技術正在革新護理方式，它直接在敷料結構內進行預測性診斷。透過將微型感測器嵌入吸水泡沫基質中，這些新一代產品使臨床醫生能夠遠端監測水分和pH值等關鍵指標，從而減少可能進一步損傷脆弱皮膚的敷料更換頻率。這項技術正迅速從實驗階段邁向臨床應用，可望提早識別感染風險。正如2025年6月發表於《臨床研究新聞》（Clinical Research News）題為“智慧繃帶技術：從動物模型到人體臨床試驗”的報導報道，一種新型智慧繃帶系統在人體臨床試驗中成功檢測到與炎症和感染相關的生物標記，且檢測時間比可見的臨床症狀出現時間提前1至3天。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球矽膠非成型敷料市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美矽膠非成型敷料市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲矽膠非成型敷料市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區矽酮非成型敷料市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲矽膠非成型敷料市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲矽膠非成型敷料市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球矽膠非成型敷料市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • MOlnlycke AB
  • Essity AB
  • Medline Industries, LP
  • Smith & Nephew Plc
  • Convatec Group Plc
  • 3M Company
  • Advancis Medical
  • Coloplast Corp
  • DermaRite Industries, LLC
  • Acto GmbH

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 27146

The Global Non-Silicone Foam Dressings Market is projected to expand from USD 552.12 Million in 2025 to USD 727.72 Million by 2031, achieving a CAGR of 4.71%. These products are typically constructed from polyurethane foam featuring either acrylic adhesives or non-adhesive interfaces, designed to effectively absorb moderate to heavy exudate while supporting moist wound healing. A primary driver for this market is the cost advantage these dressings offer over silicone-based alternatives, making them a preferred choice for budget-constrained healthcare systems. This demand is further amplified by the rising global incidence of chronic wounds, such as diabetic ulcers. For instance, a May 2024 report by Diabetes UK noted a nearly 40% increase in early-onset type 2 diabetes diagnoses over the past five years, highlighting a growing population vulnerable to conditions requiring efficient wound management.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 552.12 Million
Market Size 2031USD 727.72 Million
CAGR 2026-20314.71%
Fastest Growing Segment
Largest MarketNorth America

Despite these growth factors, the market faces significant hurdles related to skin integrity, as aggressive non-silicone adhesives can cause pain or trauma upon removal, unlike gentler silicone options. This risk of medical adhesive-related skin injury frequently leads clinicians and patients to favor silicone-based dressings, thereby limiting the adoption of non-silicone variants. This preference is particularly evident in applications involving sensitive or fragile skin, where minimizing trauma is essential. Consequently, while cost-efficiency drives market interest, the potential for skin damage remains a substantial restraint on the segment's expansion in high-risk care settings.

Market Driver

The escalating global prevalence of chronic wounds, especially diabetic foot ulcers, serves as a major growth catalyst for the Global Non-Silicone Foam Dressings Market. Individuals managing diabetes are particularly prone to developing non-healing ulcers due to complications like neuropathy and poor circulation, creating an urgent need for dressings that can handle significant exudate. Non-silicone foam dressings are widely utilized in these situations because they provide superior fluid handling at a lower cost than silicone alternatives, rendering them essential for healthcare systems dealing with high patient volumes. According to the International Diabetes Federation's 'Diabetes Atlas' update in April 2025, approximately 589 million adults aged 20-79 are currently living with diabetes worldwide, representing a vast patient base susceptible to ulceration and subsequent wound care requirements.

Simultaneously, the growing geriatric population significantly boosts market demand, as older adults are disproportionately susceptible to venous leg ulcers and pressure injuries due to age-related skin fragility and immobility. This demographic shift underscores the necessity for effective, budget-friendly wound care solutions in nursing homes and home healthcare environments, where non-silicone foams are a standard tool for treating bedsores. As stated in the World Health Organization's 'Ageing and Health' fact sheet from October 2025, the percentage of the global population over 60 is expected to nearly double from 12% in 2015 to 22% by 2050. This rising demand correlates with industry performance; for example, Smith & Nephew's 'Second Quarter and First Half 2025 Results' from August 2025 reported a 2.6% underlying revenue growth in their Advanced Wound Care business, driven specifically by gains in their foam dressing portfolio.

Market Challenge

The primary barrier hindering the growth of the Global Non-Silicone Foam Dressings Market is the risk of skin trauma associated with aggressive adhesives, known as medical adhesive-related skin injury. Unlike the gentle release provided by silicone interfaces, the rubber-based or acrylic adhesives typically used in non-silicone dressings often form a bond that is too strong for delicate tissue. Removing these dressings can strip the outer layer of the skin, resulting in significant pain and secondary wounding. This potential for damage discourages medical professionals from choosing non-silicone options for elderly patients or those with compromised skin integrity, effectively restricting the product's use in clinical settings where skin preservation is a priority.

This hesitation significantly limits the addressable market for non-silicone dressings, as the patient demographics most in need of foam dressings often exhibit skin characteristics that are incompatible with strong adhesion. The scale of this limitation becomes apparent when considering the vast number of patients requiring long-term wound management who would otherwise be candidates for these cost-effective solutions. According to the European Wound Management Association, nearly four million people in the European region were affected by chronic wounds in 2024. This substantial volume of patients requiring frequent dressing changes illustrates how the inability to safely accommodate fragile skin directly curbs the growth potential of the non-silicone segment.

Market Trends

The sector is being transformed by the integration of advanced antimicrobial and bioactive formulations, as healthcare systems increasingly prioritize active infection control alongside fluid management. This trend is driving the development of non-silicone foam dressings infused with agents such as silver or PHMB, providing a budget-conscious alternative for combating biofilm in chronic ulcers compared to premium silicone options. The momentum for these value-added solutions is evident in industry data; for instance, Smith & Nephew's 'Third Quarter 2025 Trading Report' from November 2025 indicated that their Advanced Wound Bioactives business achieved 12.2% underlying revenue growth, significantly outpacing other segments and highlighting the rising demand for chemically active dressing interfaces.

Concurrently, the adoption of smart sensor technologies for real-time wound monitoring is revolutionizing care by enabling predictive diagnostics directly within the dressing structure. By embedding micro-sensors into the absorbent foam matrix, these next-generation products allow clinicians to remotely monitor critical indicators like moisture and pH, reducing the frequency of dressing changes that can further damage fragile skin. This technology has rapidly advanced from experimental phases to clinical viability, offering the potential to preemptively identify infection risks. As reported by Clinical Research News in June 2025, in the article 'Smart Bandage Technology Advances from Animal Models to Human Clinical Testing', a human trial demonstrated that a new smart bandage system successfully detected biomarkers associated with inflammation and infection one to three days before the onset of visible clinical symptoms.

Key Market Players

  • MOlnlycke AB
  • Essity AB
  • Medline Industries, LP
  • Smith & Nephew Plc
  • Convatec Group Plc
  • 3M Company
  • Advancis Medical
  • Coloplast Corp
  • DermaRite Industries, LLC
  • Acto GmbH

Report Scope

In this report, the Global Non-Silicone Foam Dressings Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Non-Silicone Foam Dressings Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Non-Silicone Foam Dressings Market.

Available Customizations:

Global Non-Silicone Foam Dressings Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Non-Silicone Foam Dressings Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Region
    • 5.2.2. By Company (2025)
  • 5.3. Market Map

6. North America Non-Silicone Foam Dressings Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Non-Silicone Foam Dressings Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
    • 6.3.2. Canada Non-Silicone Foam Dressings Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
    • 6.3.3. Mexico Non-Silicone Foam Dressings Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast

7. Europe Non-Silicone Foam Dressings Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Non-Silicone Foam Dressings Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
    • 7.3.2. France Non-Silicone Foam Dressings Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
    • 7.3.3. United Kingdom Non-Silicone Foam Dressings Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
    • 7.3.4. Italy Non-Silicone Foam Dressings Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
    • 7.3.5. Spain Non-Silicone Foam Dressings Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast

8. Asia Pacific Non-Silicone Foam Dressings Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Non-Silicone Foam Dressings Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
    • 8.3.2. India Non-Silicone Foam Dressings Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
    • 8.3.3. Japan Non-Silicone Foam Dressings Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
    • 8.3.4. South Korea Non-Silicone Foam Dressings Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
    • 8.3.5. Australia Non-Silicone Foam Dressings Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast

9. Middle East & Africa Non-Silicone Foam Dressings Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Non-Silicone Foam Dressings Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
    • 9.3.2. UAE Non-Silicone Foam Dressings Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
    • 9.3.3. South Africa Non-Silicone Foam Dressings Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast

10. South America Non-Silicone Foam Dressings Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Non-Silicone Foam Dressings Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
    • 10.3.2. Colombia Non-Silicone Foam Dressings Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
    • 10.3.3. Argentina Non-Silicone Foam Dressings Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Non-Silicone Foam Dressings Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. MOlnlycke AB
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Essity AB
  • 15.3. Medline Industries, LP
  • 15.4. Smith & Nephew Plc
  • 15.5. Convatec Group Plc
  • 15.6. 3M Company
  • 15.7. Advancis Medical
  • 15.8. Coloplast Corp
  • 15.9. DermaRite Industries, LLC
  • 15.10. Acto GmbH

16. Strategic Recommendations

17. About Us & Disclaimer